Login / Signup

Using an Aluminum Hydroxide-Chitosan Matrix Increased the Vaccine Potential and Immune Response of Mice against Multi-Drug-Resistant Acinetobacter baumannii .

Túllio T DeusdaráMellanie K C FélixHelio de S BritoEdson W S CangussuWellington S MouraBenedito AlbuquerqueMarcos G SilvaGil Rodrigues Dos SantosPaula Benevides de MoraisElizangela F da SilvaYury O ChavesLuis Andre M MariúbaPaulo A NogueiraSpartaco Astolfi-FilhoEnedina N AssunçãoSabrina EpiphanioClaudio R F MarinhoIgor Viana BrandiKelvinson F VianaEugênio Eduardo de OliveiraAlex Sander R Cangussu
Published in: Vaccines (2023)
Acinetobacter baumannii is a Gram-negative, immobile, aerobic nosocomial opportunistic coccobacillus that causes pneumonia, septicemia, and urinary tract infections in immunosuppressed patients. There are no commercially available alternative antimicrobials, and multi-drug resistance is an urgent concern that requires emergency measures and new therapeutic strategies. This study evaluated a multi-drug-resistant A. baumannii whole-cell vaccine, inactivated and adsorbed on an aluminum hydroxide-chitosan (mAhC) matrix, in an A. baumannii sepsis model in immunosuppressed mice by cyclophosphamide (CY). CY-treated mice were divided into immunized, non-immunized, and adjuvant-inoculated groups. Three vaccine doses were given at 0D, 14D, and 28D, followed by a lethal dose of 4.0 × 10 8 CFU/mL of A. baumannii . Immunized CY-treated mice underwent a significant humoral response, with the highest IgG levels and a higher survival rate (85%); this differed from the non-immunized CY-treated mice, none of whom survived ( p < 0.001), and from the adjuvant group, with 45% survival ( p < 0.05). Histological data revealed the evident expansion of white spleen pulp from immunized CY-treated mice, whereas, in non-immunized and adjuvanted CY-treated mice, there was more significant organ tissue damage. Our results confirmed the proof-of-concept of the immune response and vaccine protection in a sepsis model in CY-treated mice, contributing to the advancement of new alternatives for protection against A. baumannii infections.
Keyphrases